The FDA sent letters to manufacturers of loperamide, a longstanding and commonly used treatment for diarrhea, asking them to change the size of the drug’s packaging to limit the amount of opioid drugs in the package. The agency aims to discontinue the large bottles in which loperamide is often sold to deter its abuse.